EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bone-Directed Drug Delivery: From Mineral and Matrix Recognition to Cellular Regulation

Raeyeong Kim, Daewon Jeong

International Journal of Molecular Sciences · 10.11.2026 · 27 (22) · 10062

DOI: 10.3390/ijms272210062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.11.2026. Verfasst von Raeyeong Kim und 1 weiteren Autor:innen. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yeungnam University, Korean government, Ministry of Science and ICT.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone-targeted drug delivery aims to increase drug exposure at diseased skeletal sites while reducing unnecessary exposure in non-skeletal tissues. Bone provides two complementary targets—the mineralized extracellular matrix and the cells regulating bone remodeling. Structural targeting uses the calcium- and phosphate-rich hydroxyapatite surfaces or collagen-rich extracellular matrix as binding sites for therapeutic cargos and delivery carriers. Cellular targeting aims to regulate osteoclasts, osteoblast-lineage cells, osteocytes, and key remodeling pathways, including receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin, Wnt/sclerostin, bone morphogenetic protein, and parathyroid hormone 1 receptor signaling. Targeting ligands and delivery platforms, including bisphosphonates, acidic oligopeptides, tetracyclines, collagen-hybridizing peptides, calcium phosphate materials, nanoparticles, aptamers, nucleic acid vectors, and extracellular vesicles, have been developed to enhance skeletal localization, prolong retention, improve cellular uptake, and control cargo release. Clinical experience with anti-RANKL antibodies, sclerostin antibodies, and parathyroid hormone receptor agonists further demonstrates the therapeutic value of regulating bone-remodeling pathways. Successful translation requires more than skeletal accumulation and should establish microanatomical localization, target-cell engagement, cargo release, therapeutic efficacy, and long-term safety. Integrating structural and cellular targeting may enable more precise treatment of osteoporosis, fracture repair, bone infection, and skeletal malignancies.

Förderung

  • Yeungnam University
  • Korean government, Ministry of Science and ICT

Zitieren

APA

Kim, R., & Jeong, D. (2026). Bone-Directed Drug Delivery: From Mineral and Matrix Recognition to Cellular Regulation. International Journal of Molecular Sciences, 27(22), 10062. https://doi.org/10.3390/ijms272210062

Vancouver

Kim R, Jeong D. Bone-Directed Drug Delivery: From Mineral and Matrix Recognition to Cellular Regulation. International Journal of Molecular Sciences. 2026;27(22):10062. doi:10.3390/ijms272210062

BibTeX
@article{Kim2026,
  author = {Kim, Raeyeong and Jeong, Daewon},
  title = {Bone-Directed Drug Delivery: From Mineral and Matrix Recognition to Cellular Regulation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10062},
  doi = {10.3390/ijms272210062}
}
Kostenlos starten →